Ratings
0
Nobody has rated this yet. Be the first!
Works
2
An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge.
Resensitization to Crizotinib by the Lorlatinib ALK Resistance Mutation L1198F.
